⌘+K

Pulse Explore Communities Researchers Journals

Home Communities Explore

March 10, 2006GutOpen Access

Crohn’s disease: why the disparity in mortality?: Table 1

Edward V. Loftus

View Full Paper

Ask AI

Bookmark

Share

Ask about this paper

Answers are grounded in this paper and cite their sources.

Ask your own question…

Abstract

There has been no significant decrease in mortality in patients with Crohn's disease over the last several decades

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Edward V. Loftus (2006) studied this question.

synapsesocial.com/papers/6ab242fd7383b113b8d63601 https://doi.org/10.1136/gut.2005.080283

View Full Paper

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 10 related papers. Consider them for comparative context:

1Divergent patterns of total and cancer mortality in ulcerative colitis and Crohn’s disease patients: the Florence IBD study 1978–2001Cohort Study · 2004 · 76 citations
2Mortality from Crohn's disease in Leicestershire, 1972-1989: an epidemiological community based study.Original Research · 1992 · 66 citations
3Has disease outcome in Crohn's disease changed during the last four decades?Prognostic Study · 2004 · 112 citations
4Incidence of inflammatory bowel disease across Europe: is there a difference between north and south? Results of the European Collaborative Study on Inflammatory Bowel Disease (EC-IBD).Cohort Study · 1996 · 1,018 citations
5Disease Outcome in Inflammatory Bowel Disease: Mortality, Morbidity and Therapeutic Management of a 796-Person Inception Cohort in the European Collaborative Study on Inflammatory Bowel Disease (EC-IBD)Cohort Study · 2000 · 67 citations
6Crohn’s disease: increased mortality 10 years after diagnosis in a Europe-wide population based cohortCohort Study · 2005 · 123 citations
7A Simple Classification of Crohnʼs Disease: Report of the Working Party for the World Congresses of Gastroenterology, Vienna 1998Retrospective Study · 2000 · 1,170 citations
8Cuproptosis of intrahepatic cholangiocytes aggravates primary biliary cholangitis through PDC-E 2 oligomerisationGut · 2026
9Beyond Spigelman: time-adaptive duodenal cancer risk in familial adenomatous polyposis – results from a retrospective two-centre study (DRACO)Gut · 2026
10Anticancer drug CX-5461 exerts pangenotypic anti-hepatitis E virus effect in human liver organoids and animal modelsGut · 2026

More from Mayo Clinic

More from Mayo Clinic in Arizona